The term “bioidentical hormone” can be confusing because it is often used as though it describes one specific type of treatment. In reality, bioidentical hormones may be available as FDA-approved medications or as customized products prepared by a compounding pharmacy.
Both categories can contain hormones that have the same chemical and molecular structure as hormones naturally produced by the human body. However, they differ significantly in how they are manufactured, tested, regulated, labeled, and prescribed.
Understanding these distinctions can help patients have more informed conversations with their healthcare providers before beginning bioidentical hormone replacement therapy.
What Does “Bioidentical” Actually Mean?
A bioidentical hormone is designed to have the same molecular structure as a hormone produced naturally by the body. Examples may include estradiol, progesterone, and testosterone.
The word does not indicate whether the medication is FDA-approved, commercially manufactured, compounded, plant-based, safer, or more effective. It describes the hormone’s structure rather than the regulatory category of the finished medication.
Some FDA-approved estradiol and micronized progesterone products are bioidentical. Compounding pharmacies may also prepare products containing estradiol, progesterone, testosterone, or combinations of hormones.
Patients should therefore ask not only whether a treatment is bioidentical but also whether the specific product is FDA-approved or compounded.
What Is an FDA-Approved Bioidentical Hormone?
An FDA-approved medication has completed the agency’s review process for a particular use. The manufacturer must provide evidence related to the medication’s quality, safety, effectiveness, dosage, manufacturing process, and labeling.
FDA-approved bioidentical hormones are available in several delivery methods, including certain tablets, patches, gels, sprays, vaginal products, and capsules. The exact options depend on the hormone and the condition being treated.
The FDA has confirmed that approved medications are available containing hormones identical to those naturally produced by the body. It also recommends using FDA-approved hormone products when an appropriate approved option meets the patient’s needs.
Approval does not mean a medication is appropriate for everyone or carries no risk. It means the finished product has undergone regulatory review and must meet established manufacturing and labeling standards.
What Is a Compounded Bioidentical Hormone?
A compounded medication is created by combining, mixing, or altering ingredients to meet the needs of an individual patient. It may be prepared by a licensed pharmacist or physician based on a prescription.
Compounding can serve an important medical purpose. For example, a patient may need a dosage strength that is not commercially available, a different delivery form, or a formulation without a specific inactive ingredient because of an allergy.
However, the finished compounded medication is not FDA-approved. The FDA does not verify its safety, effectiveness, or quality before it is marketed and dispensed.
This distinction applies even when the ingredients used in a bioidentical hormone replacement treatment are familiar or available in approved products.
How Do Manufacturing and Testing Differ?
FDA-approved medications are manufactured under standardized conditions. Each approved strength and delivery method must consistently meet established specifications.
Patients receiving the same FDA-approved product should generally receive a predictable amount of the active ingredient from one properly manufactured batch to another.
Compounded products are prepared individually or in batches under a different regulatory framework. The exact level of oversight depends partly on whether the medication comes from a traditional compounding pharmacy or an FDA-registered outsourcing facility.
Compounded medications may still be prepared carefully by qualified professionals, but the FDA does not evaluate each finished formulation before it reaches the patient. Poor compounding practices can lead to contamination or a product containing more or less active ingredient than intended.
Consistency is particularly important with hormones because relatively small dosage differences may affect symptom response, side effects, and laboratory results.
Are Compounded Hormones Safer or More Effective?
There is no reliable evidence that compounded bioidentical hormone therapy is generally safer or more effective than FDA-approved hormone therapy.
A National Academies review requested by the FDA found limited high-quality evidence supporting the safety and effectiveness of compounded bioidentical products. Much of the available information came from lower-quality evidence such as patient reports, testimonials, and anecdotal experience.
The Endocrine Society has also expressed concern about claims suggesting that compounded products are inherently safer or more effective. It supports stronger oversight related to dosage accuracy, purity, adverse-event reporting, and patient information.
The risks of hormone therapy depend on several factors, including the hormone used, dose, delivery method, treatment duration, patient’s age, medical history, and whether appropriate monitoring is performed. The word “bioidentical” does not remove those considerations.
When Might Compounding Be Medically Appropriate?
Compounding may be considered when an FDA-approved medication cannot meet a specific patient need.
A patient might require:
- A dosage strength that is not commercially available
- A formulation without an ingredient that causes an allergic reaction
- A different dosage form because they cannot swallow a tablet
- A medication that is temporarily unavailable
- A highly specific formulation for a documented clinical reason
The FDA states that compounded drugs should generally be used when a patient’s medical needs cannot be met by an FDA-approved product.
Customization should be based on a genuine medical need rather than the assumption that a customized product is automatically more natural or precise.
Do Saliva Tests Create a More Personalized Formula?
Some compounded hormone programs promote saliva testing as a way to create individualized hormone combinations. However, hormone levels may fluctuate throughout the day and can be affected by medication timing, menstrual stage, and how the sample was collected.
A single saliva measurement may not reliably determine the exact dose a person needs. Treatment decisions should instead consider symptoms, medical history, examination findings, treatment risks, and clinically appropriate laboratory testing.
A bioidentical hormone doctor may use blood tests when they are relevant, but laboratory values should not be interpreted in isolation. Hormone treatment should address a defined clinical concern rather than simply attempting to move every number toward a predetermined target.
What Should Patients Ask Before Beginning Treatment?
Patients meeting with Bioidentical Hormone Doctors can ask several practical questions:
- Is this product FDA-approved or compounded?
- Why is this formulation recommended?
- Is an approved alternative available?
- Which pharmacy or manufacturer prepares it?
- How will the dose be monitored?
- What side effects should be reported?
- How should the medication be stored?
- What happens if symptoms do not improve?
These questions are especially relevant in Arizona, where heat can affect medications that require controlled storage conditions. Hormones should not be left in parked vehicles or exposed to temperatures outside the instructions provided by the pharmacy or manufacturer.
The Difference Is About More Than the Hormone Molecule
FDA-approved and compounded products may contain structurally identical hormones, but the finished medications are not regulated or evaluated in the same way.
FDA-approved products have undergone review for safety, effectiveness, quality, manufacturing consistency, and labeling for specific uses. Compounded products offer customization when a legitimate medical need cannot be met by an approved medication, but the finished formulation does not undergo the FDA approval process.
Patients considering bioidentical hormone replacement should ask why a particular product is being recommended and how it will be monitored. The most appropriate option is not determined by whether the label says “bioidentical.” It depends on the patient’s clinical needs, available approved treatments, potential risks, and the quality of ongoing medical supervision.
